A total of 248 participants were randomised to mazdutide 3 mg ( n = 62), 4.5 mg ( n = 63), 6 mg ( n = 61) or placebo ( n = 62)
Semaglutide, one of the best-known GLP-1 medications, was developed in 2012 and later approved to treat diabetes and obesity
Compounding eligibility is separate from FDA approval and depends on the specific substance, route, pharmacy type, state rules, and current FDA policy
& Yoon, K
This peptide is supplied as a lyophilized powder in sterile glass vials, offering 99% purity and packaged for precise research applications
These medications, like phentermine or semaglutide , are FDA-approved and can help suppress appetite